These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26080071)

  • 1. Combination of an Antigen-Specific Therapy and an Immunomodulatory Treatment to Simultaneous Block Recurrent Autoimmunity and Alloreactivity in Non-Obese Diabetic Mice.
    Fousteri G; Jofra T; Di Fonte R; Battaglia M
    PLoS One; 2015; 10(6):e0127631. PubMed ID: 26080071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
    Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune destruction of islet grafts in the NOD mouse is resistant to 15-deoxyspergualin but sensitive to anti-CD4 antibody.
    Stegall MD; Loberman Z; Ostrowska A; Coulombe M; Gill RG
    J Surg Res; 1996 Aug; 64(2):156-60. PubMed ID: 8812627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation.
    Gagliani N; Gregori S; Jofra T; Valle A; Stabilini A; Rothstein DM; Atkinson M; Roncarolo MG; Battaglia M
    PLoS One; 2011; 6(12):e28434. PubMed ID: 22174806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
    Wong CP; Li L; Frelinger JA; Tisch R
    J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic overexpression of interleukin-10 fails to protect allogeneic islet transplants in nonobese diabetic mice.
    Zhang YC; Pileggi A; Molano RD; Wasserfall C; Campbell-Thompson M; Ricordi C; Atkinson MA; Inverardi L
    Transplantation; 2005 Aug; 80(4):530-3. PubMed ID: 16123729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
    Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
    Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. InsB9-23 Gene Transfer to Hepatocyte-Based Combined Therapy Abrogates Recurrence of Type 1 Diabetes After Islet Transplantation.
    Russo F; Citro A; Squeri G; Sanvito F; Monti P; Gregori S; Roncarolo MG; Annoni A
    Diabetes; 2021 Jan; 70(1):171-181. PubMed ID: 33122392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
    Demirci G; Strom TB; Li XC
    J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation with SA-FasL protein as an effective means of preventing islet allograft rejection in chemically diabetic NOD mice.
    Yolcu ES; Zhao H; Shirwan H
    Transplant Proc; 2013 Jun; 45(5):1889-91. PubMed ID: 23769064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.
    Rivereau AS; You S; Lalain S; Gouin E; Saï P
    Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet allograft rejection in sensitized mice is refractory to control by combination therapy of immune-modulating agents.
    Hong J; Yeom HJ; Lee E; Han KH; Koo TY; Cho B; Ro H; Oh KH; Ahn C; Yang J
    Transpl Immunol; 2013 Mar; 28(2-3):86-92. PubMed ID: 23357716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression With CD40 Costimulatory Blockade Plus Rapamycin for Simultaneous Islet-Kidney Transplantation in Nonhuman Primates.
    Oura T; Hotta K; Lei J; Markmann J; Rosales I; Dehnadi A; Kawai K; Ndishabandi D; Smith RN; Cosimi AB; Kawai T
    Am J Transplant; 2017 Mar; 17(3):646-656. PubMed ID: 27501203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
    Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
    Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
    Lakey JR; Singh B; Warnock GL; Rajotte RV
    Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
    Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
    Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engraftment versus immunosuppression: cost-benefit analysis of immunosuppression after intrahepatic murine islet transplantation.
    Marzorati S; Melzi R; Citro A; Cantarelli E; Mercalli A; Scavini M; Piemonti L
    Transplantation; 2014 May; 97(10):1019-26. PubMed ID: 24770621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.